In 2010, Rossi solicited investment from fellow Harvard University faculty member and serial entrepreneur Timothy A. Springer. Springer invested $5 million in the company[10] and solicited additional investments from Kenneth R. Chien, Bob Langer, and Venture Studio Flagship Ventures, run by Noubar Afeyan.[9][11] Together they founded "ModeRNA Therapeutics", named from the combined terms "modified" and "RNA" that just happens to contain "modern".[12]
Mode rna.
Or Mod (th)e RNA?
It's an amalgamation of Modified and RNA https://en.wikipedia.org/wiki/Moderna